article thumbnail

Pharma’s Productivity Problem: Finding More Blockbuster Drugs

Xconomy

pension funds) with little appetite for experimentation with new managers and more funds. A 2011 white paper by Kevin Lalande of Santé Ventures explains why the … Next Page » Reprints | Share: UNDERWRITERS AND PARTNERS.

Product 40